The stock hit a day high of Rs 2606.05 per share, up 0.84 percent from its previous close of Rs 2584.50 per share. Year to date, the stock has returned 8.42 per cent.

Amid severe selling pressure, domestic equities fell for the third session in a row on Thursday.

The company has a normal PE multiple of 14, while the sectoral PE multiple is 23.2. The company's ROE is 16.11 per cent and its ROCE is 18.12 percent. In just 6 months, the stock gained 45.12 per cent. Everything points to incredible managerial performance.

Company’s shares jumped after receiving approval from Brazil’s National Health Surveillance Agency for its injectable formulations manufacturing units.

Here are the top gaining stocks in BSE Group ‘A’.

The scrip surged more than 4 per cent despite market weakness. 

Indices experienced a roller coaster ride as indices recovered points from their day’s low, only to witness selling pressure at higher levels. In the end, NSE Nifty 50 index closed at the 18,100 level and near its day’s low while S&P BSE Sensex slipped 250 points.

Today, the stock jumped nearly 4 per cent in the morning trade.

On Thursday, the major market indices kept experiencing modest losses. 

Are you looking for stocks to trade? Checkout this article that lists stocks with positive breakout despite a falling market.